# NLI Holdings, Inc.: overview

NL · NYSE · CIK 72162 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nl.md) · [Financials](/companies/nl/financials.md) · [Filings](/companies/nl/filings.md) · [Insiders](/companies/nl/insiders.md)

Latest reported revenue: [$43.6m](/filings/0001104659-26-091146.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-091146).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [33.7](/filings/0001104659-25-107766.md) | [38.4 d](/filings/0001104659-26-025290.md) | [40.3](/filings/0001104659-26-056285.md) | [40.4](/filings/0001104659-26-091146.md) | [40.0](/filings/0001104659-25-107766.md) | [37.7 d](/filings/0001104659-26-025290.md) | [40.6](/filings/0001104659-26-056285.md) | [43.6](/filings/0001104659-26-091146.md) |
| Gross margin | % | [28.1%](/filings/0001104659-25-107766.md) | [28.8% d](/filings/0001104659-26-025290.md) | [30.2%](/filings/0001104659-26-056285.md) | [31.9%](/filings/0001104659-26-091146.md) | [27.6%](/filings/0001104659-25-107766.md) | [32.1% d](/filings/0001104659-26-025290.md) | [32.7%](/filings/0001104659-26-056285.md) | [35.6%](/filings/0001104659-26-091146.md) |
| Operating margin | % | [6.0%](/filings/0001104659-25-107766.md) | [87.7% d](/filings/0001104659-26-025290.md) | [7.8%](/filings/0001104659-26-056285.md) | [6.9%](/filings/0001104659-26-091146.md) | [4.6%](/filings/0001104659-25-107766.md) | [7.6% d](/filings/0001104659-26-025290.md) | [10.1%](/filings/0001104659-26-056285.md) | [14.1%](/filings/0001104659-26-091146.md) |
| Net margin | % | [107.0%](/filings/0001104659-25-107766.md) | [43.1% d](/filings/0001104659-26-025290.md) | [1.7%](/filings/0001104659-26-056285.md) | [0.9%](/filings/0001104659-26-091146.md) | [(19.7%)](/filings/0001104659-25-107766.md) | [(82.2%) d](/filings/0001104659-26-025290.md) | [10.7%](/filings/0001104659-26-056285.md) | [20.5%](/filings/0001104659-26-091146.md) |
| Diluted EPS | $ per share | [0.74](/filings/0001104659-25-107766.md) | not reported | [0.01](/filings/0001104659-26-056285.md) | [0.01](/filings/0001558370-25-010532.md) | [(0.16)](/filings/0001104659-25-107766.md) | not reported | [0.09](/filings/0001104659-26-056285.md) | not reported |
| Free cash flow | $m | [(6.1) d](/filings/0001104659-25-107766.md) | [8.7 d](/filings/0001104659-26-025290.md) | [(48.3)](/filings/0001104659-26-056285.md) | [5.9 d](/filings/0001104659-26-091146.md) | [7.0 d](/filings/0001104659-25-107766.md) | [(4.7) d](/filings/0001104659-26-025290.md) | [(3.9)](/filings/0001104659-26-056285.md) | [9.8 d](/filings/0001104659-26-091146.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [141](/filings/0001558370-24-002620.md) | [167](/filings/0001558370-25-002417.md) | [161](/filings/0001104659-26-025290.md) | [146](/filings/0001104659-26-025290.md) | [158](/filings/0001104659-26-025290.md) |
| Gross margin | % | [30.4%](/filings/0001558370-24-002620.md) | [29.3%](/filings/0001558370-25-002417.md) | [30.5%](/filings/0001104659-26-025290.md) | [28.3%](/filings/0001104659-26-025290.md) | [30.4%](/filings/0001104659-26-025290.md) |
| Operating margin | % | [7.5%](/filings/0001558370-24-002620.md) | [8.2%](/filings/0001558370-25-002417.md) | [8.8%](/filings/0001104659-26-025290.md) | [26.0%](/filings/0001104659-26-025290.md) | [6.7%](/filings/0001104659-26-025290.md) |
| Net margin | % | [36.4%](/filings/0001558370-24-002620.md) | [20.3%](/filings/0001558370-25-002417.md) | [(1.4%)](/filings/0001104659-26-025290.md) | [46.1%](/filings/0001104659-26-025290.md) | [(23.9%)](/filings/0001104659-26-025290.md) |
| Diluted EPS | $ per share | [1.05](/filings/0001558370-24-002620.md) | [0.69](/filings/0001558370-25-002417.md) | [(0.05)](/filings/0001104659-26-025290.md) | [1.38](/filings/0001104659-26-025290.md) | [(0.77)](/filings/0001104659-26-025290.md) |
| Free cash flow | $m | [13.5](/filings/0001558370-24-002620.md) | [23.2](/filings/0001558370-25-002417.md) | [35.9](/filings/0001104659-26-025290.md) | [24.1](/filings/0001104659-26-025290.md) | [(40.2)](/filings/0001104659-26-025290.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $12.2m | 2,058,135 |  | Reduced −31,032 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.2m | 540,104 |  | Added +10,395 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.9m | 324,989 |  | Added +3,797 |
| [Aristides Capital LLC](/funds/1595521.md) | 2026-06-30 | $1.9m | 312,962 |  | Reduced −104,052 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $1.9m | 310,993 |  | Reduced −15,000 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $1.5m | 257,968 |  | Added +237,658 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.3m | 217,427 |  | Reduced −7,087 |
| [Empowered Funds, LLC](/funds/1592828.md) | 2026-06-30 | $1.3m | 217,131 |  | Reduced −15,000 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.1m | 182,714 |  | Added +20,244 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $796.0k | 133,777 |  | Added +56 |

## Recent filings

[All 472 filings](/companies/nl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:16 ET | [8-K](/filings/0000072162-26-000042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000072162-26-000042 |
| 2026-08-05 | 16:26 ET | [10-Q](/filings/0001104659-26-091146.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091146 |
| 2026-08-05 | 16:22 ET | [8-K](/filings/0000072162-26-000039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000072162-26-000039 |
| 2026-05-26 | 16:16 ET | [8-K](/filings/0000072162-26-000034.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000072162-26-000034 |
| 2026-05-14 | 16:17 ET | [8-K](/filings/0000072162-26-000028.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000072162-26-000028 |
| 2026-05-06 | 16:26 ET | [10-Q](/filings/0001104659-26-056285.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056285 |
| 2026-05-06 | 16:21 ET | [8-K](/filings/0000072162-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000072162-26-000025 |
| 2026-03-25 | 16:15 ET | [DEF 14A](/filings/0000072162-26-000018.md) | Proxy statement, period 2026-05-14 | 0000072162-26-000018 |
| 2026-03-09 | 16:40 ET | [10-K](/filings/0001104659-26-025290.md) | Annual report, period 2025-12-31 | 0001104659-26-025290 |
| 2026-03-09 | 16:20 ET | [8-K](/filings/0000072162-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000072162-26-000009 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-025290.md), filed Mar 9, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3dea4a23-cd6a-4745-87a5-180a584c1a8c)

## About the filer

- CIK: 72162
- Tickers: NL
- Exchange: NYSE
- SIC code: 2810 Industrial Inorganic Chemicals
- State of incorporation: DE
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:17 ET. No prices; not investment advice.